52
Views
4
CrossRef citations to date
0
Altmetric
Review

Aclidinium bromide/formoterol fixed-dose combination therapy for COPD: the evidence to date

, &
Pages 1989-1999 | Published online: 07 Apr 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Nicola A Hanania, Suzanne C. Lareau & Barbara P. Yawn. (2017) Safety of inhaled long-acting anti-muscarinic agents in COPD. Postgraduate Medicine 129:5, pages 500-512.
Read now
Cristoforo Incorvaia, Marcello Montagni, Elena Makri & Erminia Ridolo. (2016) New combinations in the treatment of COPD: rationale for aclidinium–formoterol. Therapeutics and Clinical Risk Management 12, pages 209-215.
Read now
Maria Gabriella Matera, Alessandro Sanduzzi & Mario Cazzola. (2016) Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 73-79.
Read now

Articles from other publishers (1)

Caimei Tan, Huijuan Huang, Jianquan Zhang, Zhiyi He, Xiaoning Zhong & Jing Bai. (2016) Effects of Low-Dose and Long-Term Treatment with Erythromycin on Interleukin-17 and Interleukin-23 in Peripheral Blood and Induced Sputum in Patients with Stable Chronic Obstructive Pulmonary Disease. Mediators of Inflammation 2016, pages 1-11.
Crossref